Most people should wait at least five to six days after symptoms start before retesting with a rapid antigen test. Retesting too early almost guarantees another positive result and tells you nothing useful about whether you’re still contagious. The timing matters because your body sheds viral RNA for weeks, but the window in which you can actually spread the virus to others is much shorter. The type of test you use for retesting matters just as much as when you take it, and the two choices give you very different information.
Why PCR Tests Are the Wrong Tool for Retesting
If you’re retesting to figure out whether you can safely leave isolation, a PCR test will mislead you. PCR detects tiny fragments of viral genetic material and remains positive long after you’ve stopped being infectious. A systematic review covering more than 3,200 individuals found that the average duration of detectable viral RNA in the upper respiratory tract was 17 days, yet no study in the review was able to grow live virus from samples collected beyond nine days after illness began.1PubMed Central. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis In plain terms, the PCR test keeps picking up dead viral debris for about a week longer than the virus is actually capable of infecting anyone.
This gap between RNA detection and actual infectiousness is the source of enormous confusion. People retest with PCR on day seven, get a positive result, panic, and extend their isolation unnecessarily. The test is doing exactly what it was designed to do: finding vanishingly small amounts of genetic material. It just isn’t answering the question you’re actually asking, which is “can I still spread this?”
Rapid Antigen Tests Track Contagiousness Much More Closely
A rapid antigen test is the right retesting tool because it correlates far better with whether live, transmissible virus is present. One study comparing antigen test results with viral cultures found that a negative antigen test had a negative predictive value of 99.9% for contagiousness, meaning that when the rapid test came back negative, it was nearly certain that no culturable virus remained.2PubMed Central. The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19 That makes it a practical, at-home tool for deciding when it’s safe to re-enter the world.
The sensitivity of antigen tests depends heavily on timing. During the first six days of symptoms, when viral loads are highest, sensitivity reaches 100% on most test platforms.3PubMed Central. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays After that, as viral load drops, antigen tests naturally become less sensitive, and that declining sensitivity is actually working in your favor: the test stops being positive right around the time you stop being contagious. False negatives in the study tended to cluster around day 11 and beyond, when patients had low viral loads that were unlikely to transmit infection.
A CDC-backed study from late 2022 and early 2023 confirmed this pattern, finding that antigen test positivity peaked about three days after symptom onset and culture positivity peaked at about two days after onset.4MMWR. Morbidity and Mortality Weekly Report. SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023 The antigen test curve lagged just slightly behind the culture curve, which is exactly what you’d want from a retesting tool: it stays positive while you’re infectious and turns negative shortly after.
The Five-to-Six Day Window
Putting together the viral shedding data and antigen test performance, day five or six after symptom onset is the earliest point at which retesting with a rapid antigen test gives you genuinely useful information. Before that, you’re almost certainly still shedding enough virus to be contagious. A study of Omicron-infected individuals found that on day five, about 83% still had positive viral cultures, meaning they were actively shedding live virus. By day seven that had dropped to roughly half, by day ten to about 14%, and by day fourteen to 8%.5PubMed Central. Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms
A cost-effectiveness analysis modeled various isolation and testing strategies and found that the most cost-effective approach was performing an antigen test on day six of a ten-day isolation period. Testing on day five of an eight-day isolation was the next-best option. Both outperformed ending isolation on day five without any testing at all, which the model estimated would lead to substantially more secondary infections.6PubMed Central. COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis PCR testing on day five was actually worse than antigen testing on day six in terms of both cost and transmission outcomes, reinforcing the point that PCR is the wrong tool for this job.
So the practical approach: take a rapid antigen test starting around day five or six. If it’s negative, you’re very likely no longer contagious. If it’s still positive, wait a day or two and test again. Two consecutive negative antigen tests spaced about 48 hours apart give you strong confidence that you’ve cleared the infectious phase.
When Viral Load Peaks and Why It Matters for Your Timeline
Your countdown starts from symptom onset, not from the date you first tested positive. That distinction matters because viral loads follow a predictable arc that is anchored to when symptoms appear. With recent variants, viral load tends to rise from the day symptoms begin and peak around day three or four.7PubMed Central. The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs One Omicron-focused study found peak viral loads arriving two to three days after disease onset.8PubMed Central. Longitudinal observation of viral load in patients infected with Omicron variant and its relationship with clinical symptoms
This is a shift from earlier in the pandemic. With the original virus and the Delta variant, peak viral loads tended to hit earlier and sometimes preceded symptoms. The practical consequence for retesting is that with current variants, you should not expect your antigen test to turn negative before day five even if you feel better sooner. Your immune system is still fighting peak-level virus on days three and four, and the test will reflect that.
Variant differences also affect how long viral shedding lasts. Across the major variants, though, the window during which live, culturable virus can be recovered has remained surprisingly consistent: replication-competent virus generally isn’t isolated beyond about ten days after symptom onset, whether the infecting variant is Delta or Omicron.5PubMed Central. Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms The RNA shedding duration differs between variants and sub-lineages, with Omicron BA.2 producing longer RNA persistence than BA.1, but the infectiousness window hasn’t stretched in the same way.1PubMed Central. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
Retesting If You Never Had Symptoms
If you tested positive but never developed symptoms, figuring out when to retest is trickier because you don’t have a clear “day one.” Your countdown instead starts from the date of your first positive test. The general recommendation is the same: retest with a rapid antigen test starting five to six days after that initial positive.
There’s an interesting wrinkle in the data on asymptomatic infections. One study from a quarantine cohort found that the time to viral clearance was essentially identical between symptomatic and asymptomatic individuals, averaging about 12 days by PCR.9PubMed Central. The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects A Korean study found similar results, with asymptomatic patients converting to their first negative test at a median of 17 days versus about 19.5 days for symptomatic patients, a difference that wasn’t statistically significant. However, asymptomatic patients’ viral loads in lower respiratory samples appeared to decline more slowly.10JAMA Internal Medicine. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea
Remember, though, these timelines are based on PCR detection, not infectiousness. The actual window during which asymptomatic people spread the virus is likely no longer than for symptomatic people and may be shorter, since symptoms like coughing actively disperse viral particles. The antigen-test retesting strategy still applies: start testing on day five or six from your positive result, and two negative antigen tests spaced a day or two apart should give you reliable clearance.
Paxlovid Rebound Changes the Retesting Calculus
If you took Paxlovid (nirmatrelvir/ritonavir) and your symptoms improved, don’t assume you’re in the clear just because you finished the five-day course. Viral rebound after antiviral treatment is a real phenomenon and it changes when and how you should retest. One large study found that about 3.5% of Paxlovid-treated patients had a return of positive COVID tests within seven days of finishing treatment, and roughly 5.4% rebounded within 30 days.11PubMed Central. COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
A prospective cohort study found even higher rebound rates: about 14% of Paxlovid-treated participants had viral rebound (meaning their viral load rose again after dropping), compared to about 9% in untreated patients. Symptom rebound was also more common with Paxlovid, occurring in roughly 19% versus 7% of untreated individuals.12medRxiv. The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants Modeling work has suggested that this rebound phenomenon is linked to the interplay between the drug suppressing viral replication and the immune system’s delayed development of a full response, with vaccinated patients being more prone to it because their immune systems may rely on the drug’s suppression rather than mounting a fresh attack.13PubMed Central. A mathematical model of SARS-CoV-2 immunity predicts paxlovid rebound
For practical retesting purposes, if you took Paxlovid, you should not count your initial negative antigen test after treatment as final clearance. Retest again two to three days later. If symptoms return after you thought you were improving, test immediately regardless of what day you’re on. Rebound typically happens within the first week after finishing the drug course, so staying alert during days six through twelve from your original symptom onset is especially important. If you do rebound, you’re contagious again during that period and should re-isolate and restart your retesting clock.
Immunocompromised People Need a Longer Runway
Standard retesting timelines don’t apply the same way if your immune system is significantly weakened. A study of immunocompromised patients found that about a quarter tested positive by PCR for 21 days or longer after illness began, and 8% still had detectable live virus for more than 21 days. The median time to a last positive test was nine days overall, but patients with B-cell cancers and people living with AIDS had significantly longer infections than those with autoimmune conditions or other cancer types.14PubMed. Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID-19: A prospective cohort study
That same study found that about half of immunocompromised COVID patients shed viable virus for four weeks or longer from diagnosis, especially among unvaccinated people receiving B-cell-depleting therapies. Being vaccinated with at least three doses was strongly protective against prolonged shedding. If you’re immunocompromised, the safe approach is to extend your retesting window and continue rapid antigen testing well past the standard five-to-six-day mark, possibly up to 20 days or longer, until you get two consecutive negative results. Discuss your specific situation with your care team, because the range of immune conditions and their effects on viral clearance is enormous.
How to Read a Faint Line and Other Practical Testing Details
A faint line on a rapid antigen test is still a positive result. People frequently dismiss faint positives as “almost negative,” but any visible line in the test region means viral protein was detected. That said, there’s a grain of truth to the intuition that a faint line means less virus. Research has shown a moderate correlation between how quickly the test line appears and the actual viral load: faster appearance corresponds to higher viral loads.15PubMed Central. Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept A faint line that takes the full 15 minutes to appear suggests a lower viral load than a dark line that shows up in two minutes. But for the purpose of deciding whether you can end isolation, both mean “still positive, still potentially contagious.”
A few additional points on the mechanics of retesting at home. Test in the morning before eating, drinking, or brushing your teeth. Your nasal passages accumulate viral material overnight, giving the swab the best chance of picking up whatever virus is present. Follow the timing instructions on the test kit exactly and don’t read the result after the window closes, since evaporation lines can mimic a faint positive. If you’ve been using tests that are past their printed expiration date, be aware that the FDA extended the shelf life of many approved tests, but sensitivity can decline with age regardless of extensions.
The Psychological Weight of Waiting for a Negative
There’s a dimension to retesting that has nothing to do with virology. Testing positive, and then continuing to test positive days later, creates real psychological strain. A longitudinal population study found that psychological distress spiked by about a third of a standard deviation during the two-week period when people first tested positive, remained elevated for an additional two weeks, and then returned to baseline levels. Severity of symptoms was the main driver: people whose symptoms were worse and slower to resolve experienced more sustained distress.16PubMed Central. Acute and longer-term psychological distress associated with testing positive for COVID-19: longitudinal evidence from a population-based study of US adults – Section: Results
Repeated positive results on rapid tests can amplify this. If you understand the biology, you can avoid some of the anxiety: a positive antigen test on day six doesn’t mean you’re getting sicker or that you’re an unusually severe case. It means your immune system is still mopping up a substantial amount of virus, which is perfectly normal for that stage. The emotional relief of finally seeing a negative test is real, but testing obsessively every few hours won’t change the result. Once a day starting on day five or six is enough.
When Retesting Isn’t About You
Some retesting isn’t for your own peace of mind but to protect someone else. If you live with an elderly person, a newborn, or someone on immunosuppressive medication, the stakes of ending isolation too early are higher. In those cases, the two-consecutive-negative-tests approach is worth the extra patience. Space the tests at least 24 hours apart, ideally 48, and keep masking around vulnerable household members even after your first negative if you can. The cost-effectiveness analysis mentioned earlier found that testing on day six and remaining in isolation until a negative result produced far fewer secondary infections than simply walking out of isolation on day five.6PubMed Central. COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
If someone in your household tests positive shortly after you, their retesting clock is separate from yours. Each person’s viral load timeline starts from their own symptom onset or first positive test. Two people infected on the same day can have very different clearance timelines depending on vaccination status, immune function, and whether they received antivirals.
Retesting for Travel or Work Requirements
Some workplaces and international destinations still require a negative test before you can return or enter. If the requirement specifies a PCR test, you may have a problem. Because PCR can remain positive for an average of 17 days and sometimes longer, you could be functionally recovered and non-contagious but still unable to produce a negative PCR result. There’s no reliable way to speed up PCR clearance. If you’re facing a PCR requirement and testing positive well past day ten, the likeliest explanation is residual RNA, not ongoing infectiousness. Some countries and employers have shifted to accepting antigen tests or medical clearance letters for exactly this reason.
If the requirement specifies an antigen test, the timeline described throughout this article applies. Most people with healthy immune systems will produce a negative rapid test somewhere between days six and ten. Having a small stockpile of tests on hand before you get sick saves the logistical headache of trying to acquire them while you’re symptomatic and isolated. Two or three boxes of a reliable rapid antigen test, stored according to the package instructions, gives you the flexibility to test at the right intervals without relying on same-day delivery during your infection.